StockStory
2 Cash-Producing Stocks with Promising Prospects and 1 Facing Challenges
➖
AI Sentiment
Neutral
4/10
- Home
- ALHC
as of 03-23-2026 3:51pm EST
$17.57
+$0.30
+1.77%
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 3.8B | IPO Year: | 2021 |
| Target Price: | $23.00 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | 100.00 |
| 52 Week Low/High: | $11.63 - $23.86 | Next Earning Date: | 04-30-2026 |
| Revenue: | $3,948,719,000 | Revenue Growth: | 46.06% |
| Revenue Growth (this year): | 33.69% | Revenue Growth (next year): | 24.74% |
| P/E Ratio: | 405.00 | Index: | N/A |
| Free Cash Flow: | 113.1M | FCF Growth: | N/A |
AI-Powered ALHC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 78.98%
78.98%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
Wagner Andreas P.
Sell
Chief Human Resources Officer
ALHC Mar 19, 2026
Avg Cost/Share
$18.22
Shares
11,602
Total Value
$211,396.56
Owned After
148,628
SEC Form 4
Scavo Robert L.
Sell
Chief Information Officer
ALHC Mar 18, 2026
Avg Cost/Share
$17.84
Shares
11,285
Total Value
$201,324.40
Owned After
487,685
SEC Form 4
KAO JOHN E
Sell
Chief Executive Officer
ALHC Mar 18, 2026
Avg Cost/Share
$17.84
Shares
73,046
Total Value
$1,303,140.64
Owned After
1,784,868
SEC Form 4
Wagner Andreas P.
Sell
Chief Human Resources Officer
ALHC Mar 18, 2026
Avg Cost/Share
$17.84
Shares
12,000
Total Value
$214,080.00
Owned After
148,628
SEC Form 4
Burzacchi Sebastian
Sell
COO - Mgmt Services Org
ALHC Mar 18, 2026
Avg Cost/Share
$17.84
Shares
15,361
Total Value
$274,040.24
Owned After
258,630
SEC Form 4
Maroney Dawn Christine
Sell
President
ALHC Mar 18, 2026
Avg Cost/Share
$17.84
Shares
36,749
Total Value
$655,602.16
Owned After
1,058,813
SEC Form 4
JOYCE CHRISTOPHER J
Sell
Chief Legal and Admin. Officer
ALHC Mar 18, 2026
Avg Cost/Share
$17.84
Shares
25,125
Total Value
$448,230.00
Owned After
323,464
SEC Form 4
Maroney Dawn Christine
Sell
President
ALHC Mar 16, 2026
Avg Cost/Share
$17.48
Shares
30,000
Total Value
$524,427.00
Owned After
1,058,813
SEC Form 4
KAO JOHN E
Sell
Chief Executive Officer
ALHC Mar 10, 2026
Avg Cost/Share
$18.19
Shares
180,000
Total Value
$3,273,552.00
Owned After
1,784,868
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Wagner Andreas P. | ALHC | Chief Human Resources Officer | Mar 19, 2026 | Sell | $18.22 | 11,602 | $211,396.56 | 148,628 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 18, 2026 | Sell | $17.84 | 11,285 | $201,324.40 | 487,685 | |
| Kim Hyong | ALHC | Chief Medical Officer | Mar 18, 2026 | Sell | $17.84 | 18,404 | $328,327.36 | 367,701 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Mar 18, 2026 | Sell | $17.84 | 73,046 | $1,303,140.64 | 1,784,868 | |
| Wagner Andreas P. | ALHC | Chief Human Resources Officer | Mar 18, 2026 | Sell | $17.84 | 12,000 | $214,080.00 | 148,628 | |
| Burzacchi Sebastian | ALHC | COO - Mgmt Services Org | Mar 18, 2026 | Sell | $17.84 | 15,361 | $274,040.24 | 258,630 | |
| Maroney Dawn Christine | ALHC | President | Mar 18, 2026 | Sell | $17.84 | 36,749 | $655,602.16 | 1,058,813 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Mar 18, 2026 | Sell | $17.84 | 25,125 | $448,230.00 | 323,464 | |
| Maroney Dawn Christine | ALHC | President | Mar 16, 2026 | Sell | $17.48 | 30,000 | $524,427.00 | 1,058,813 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Mar 10, 2026 | Sell | $18.19 | 180,000 | $3,273,552.00 | 1,784,868 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 26, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 26, 2026 · 100% conf.
AI Prediction BUY
1D
+8.42%
$22.14
Act: -5.63%
5D
+12.18%
$22.91
Act: -9.06%
20D
+21.31%
$24.77
Price: $20.42 Prob +5D: 100% AUC: 1.000
0001171843-26-001139
Form 8-KFalse000183246600018324662026-02-262026-02-26iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026
Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter)
Delaware001-4029546-5596242 (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.) 1100 W. Town and Country Road, Suite 1600 Orange, California 92868 (Address of Principal Executive Offices) (Zip Code) (844) 310-2247 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.001 per shareALHCThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On February 26, 2026, Alignment Healthcare, Inc. issued a press release announcing its financial results for its fourth quarter and full year ended Dec. 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information contained in this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Description
99.1 Press Release dated February 26, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alignment Healthcare, Inc.
Date: February 26, 2026By: /s/ James M. Head James M. Head Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 30, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 30, 2025
0001171843-25-006831
Form 8-KFalse000183246600018324662025-10-302025-10-30iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2025
Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter)
Delaware001-4029546-5596242 (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.) 1100 W. Town and Country Road, Suite 1600 Orange, California 92868 (Address of Principal Executive Offices) (Zip Code) (844) 310-2247 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.001 per shareALHCThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On October 30, 2025, Alignment Healthcare, Inc. issued a press release announcing its financial results for its third quarter ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information contained in this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Description
99.1 Press Release dated October 30, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alignment Healthcare, Inc.
Date: October 30, 2025By: /s/ James M. Head James M. Head Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 30, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 30, 2025
0001171843-25-004825
Form 8-KFalse000183246600018324662025-07-302025-07-30iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025
Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter)
Delaware001-4029546-5596242 (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.) 1100 W. Town and Country Road, Suite 1600 Orange, California 92868 (Address of Principal Executive Offices) (Zip Code) (844) 310-2247 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.001 per shareALHCThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On July 30, 2025, Alignment Healthcare, Inc. issued a press release announcing its financial results for its second quarter ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information contained in this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Description
99.1 Press Release dated July 30, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alignment Healthcare, Inc.
Date: July 30, 2025By: /s/ James M. Head James M. Head Chief Financial Officer
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
MT Newswires
Alignment Healthcare Insider Sold Shares Worth $328,327, According to a Recent SEC Filing
➖
AI Sentiment
Neutral
4/10
MT Newswires
Alignment Healthcare Insider Sold Shares Worth $274,040, According to a Recent SEC Filing
➖
AI Sentiment
Neutral
5/10
MT Newswires
Alignment Healthcare Insider Sold Shares Worth $1,303,141, According to a Recent SEC Filing
➖
AI Sentiment
Neutral
4/10
Compare ALHC vs Leading Stocks
See how ALHC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.